butyric acid has been researched along with vorinostat in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 10 (71.43) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bello, SH; Liénard, BM; McDonough, MA; Mecinović, J; Ng, SS; Oppermann, U; Rose, NR; Schofield, CJ; Sun, Z | 1 |
| Bora-Tatar, G; Dalkara, S; Dayangaç-Erden, D; Demir, AS; Erdem-Yurter, H; Yelekçi, K | 1 |
| Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V | 1 |
| Bader, P; Beck, JF; Gänge, J; Kumar, KS; Müller, C; Sonnemann, J | 1 |
| Kidd, SK; Schneider, JS | 1 |
| Cobiac, L; Humphreys, KJ; Le Leu, RK; Michael, MZ; Van der Hoek, MB | 1 |
| Correia, AO; da Graça Naffah-Mazzacorati, M; de Castro Brito, GA; de Oliveira Gonçalves, D; Félix, FH; Leal, LK; Neves, KR; Santos Cerqueira, G; Siqueira, RM; Viana, GS; Ximenes, JC | 1 |
| Dai, L; Qian, L; Tan, M; Wan, X; Wang, J; Wu, Y; Wu, Z; Xu, G; Zhao, Y | 1 |
| Chiarugi, A; Gerace, E; Landucci, E; Moroni, F; Pellegrini-Giampietro, DE; Scartabelli, T | 1 |
| Beck, M; Bork, P; Iskar, M; Mackmull, MT; Ori, A; Parca, L; Singer, S | 1 |
| Blanco, FF; Dixon, DA; Hu, L; Sanduja, S; Sobolewski, C | 1 |
| Chen, ZJ; Du, J; Jiang, GM; Liu, T; Wang, HS; Wang, ZT; Wu, YM; Yi, YM; Zeng, J | 1 |
| Kotantaki, P; Mosialos, G | 1 |
| Fisher, CA; Gibbons, RJ; Higgs, DR; Mettananda, S; Oppermann, U; Sloane-Stanley, JA; Taylor, S | 1 |
2 review(s) available for butyric acid and vorinostat
| Article | Year |
|---|---|
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction | 2022 |
Histone deacetylase inhibitors interact synergistically with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to induce apoptosis in carcinoma cell lines.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Butyric Acid; Caspase 3; Caspases; Cell Line, Tumor; Drug Synergism; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Membrane Glycoproteins; Prostatic Neoplasms; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vorinostat | 2005 |
12 other study(ies) available for butyric acid and vorinostat
| Article | Year |
|---|---|
Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases.
Topics: Crystallography, X-Ray; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Ketoglutaric Acids; Models, Molecular; Molecular Structure; Oxidoreductases, N-Demethylating; Protein Structure, Tertiary; Stereoisomerism; Structure-Activity Relationship | 2008 |
Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
Topics: Caffeic Acids; Carboxylic Acids; Catalytic Domain; Chlorogenic Acid; Curcumin; Enzyme Inhibitors; HeLa Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Models, Molecular; Molecular Structure; Protein Binding | 2009 |
Protection of dopaminergic cells from MPP+-mediated toxicity by histone deacetylase inhibition.
Topics: 1-Methyl-4-phenylpyridinium; Acetylation; Analysis of Variance; Animals; Apoptosis; Butyric Acid; Cell Line; Cells, Cultured; Dopamine; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Immunohistochemistry; Nerve Degeneration; Neurons; Rats; Valproic Acid; Vorinostat | 2010 |
Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster.
Topics: Adaptor Proteins, Signal Transducing; Adenocarcinoma; Apoptosis Regulatory Proteins; Bcl-2-Like Protein 11; Butyric Acid; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Gene Expression Regulation, Neoplastic; HCT116 Cells; Histone Deacetylase Inhibitors; HT29 Cells; Humans; Hydroxamic Acids; Membrane Proteins; MicroRNAs; Phosphoproteins; Proto-Oncogene Proteins; PTEN Phosphohydrolase; RNA, Long Noncoding; RNA, Messenger; Transfection; Vorinostat | 2013 |
Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Anticonvulsants; Butyric Acid; Carrageenan; Drug Synergism; Edema; Foot; Formaldehyde; Hot Temperature; Hydroxamic Acids; Leukocyte Count; Male; Mice; Pain; Pentoxifylline; Peritonitis; Peroxidase; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Valproic Acid; Vorinostat | 2013 |
SAHA regulates histone acetylation, Butyrylation, and protein expression in neuroblastoma.
Topics: Acetylation; Amino Acid Sequence; Antineoplastic Agents; Blotting, Western; Butyric Acid; Cell Line, Tumor; Chromatography, High Pressure Liquid; Histones; Humans; Hydroxamic Acids; Molecular Sequence Data; Neoplasm Proteins; Neuroblastoma; Tandem Mass Spectrometry; Vorinostat | 2014 |
Interplay between histone acetylation/deacetylation and poly(ADP-ribosyl)ation in the development of ischemic tolerance in vitro.
Topics: Acetylation; Animals; Animals, Newborn; Butyric Acid; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Glucose; Hippocampus; Histones; Hydroxamic Acids; Hypoxia; In Vitro Techniques; N-Methylaspartate; Neurons; Organ Culture Techniques; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Signal Transduction; Time Factors; Vorinostat | 2015 |
Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs).
Topics: Acetylation; Butyric Acid; Carrier Proteins; Cell Cycle Proteins; Co-Repressor Proteins; CREB-Binding Protein; DNA-Binding Proteins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Silencing; HeLa Cells; Histone Acetyltransferases; Histone Chaperones; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Nuclear Proteins; Protein Processing, Post-Translational; RNA, Small Interfering; Transcription Factors; Transcription, Genetic; Vorinostat | 2015 |
Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells.
Topics: Butyric Acid; Cell Line, Tumor; Colorectal Neoplasms; Cyclooxygenase 2; Early Growth Response Protein 1; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; RNA, Messenger; Tristetraprolin; Vorinostat | 2015 |
Histone deacetylase inhibitors suppress mutant p53 transcription via HDAC8/YY1 signals in triple negative breast cancer cells.
Topics: Apoptosis; Butyric Acid; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Mitochondria; Mutation; Repressor Proteins; Signal Transduction; Transcription, Genetic; Triple Negative Breast Neoplasms; Tumor Suppressor Protein p53; Vorinostat; YY1 Transcription Factor | 2016 |
The expression of tumor suppressor gene Cyld is upregulated by histone deacetylace inhibitors in human hepatocellular carcinoma cell lines.
Topics: Butyric Acid; Carcinoma, Hepatocellular; Cell Line, Tumor; Deubiquitinating Enzyme CYLD; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Liver Neoplasms; Tumor Suppressor Proteins; Up-Regulation; Vorinostat | 2016 |
Selective silencing of α-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of β-thalassemia.
Topics: alpha-Globins; Antigens, CD34; beta-Thalassemia; Butyric Acid; Cell Culture Techniques; Enzyme Inhibitors; Erythroid Cells; Gene Expression Profiling; Gene Expression Regulation; Histone Demethylases; Histones; Humans; Hydroxamic Acids; Hydroxyquinolines; Hydroxyurea; Molecular Sequence Annotation; Piperazines; RNA, Small Interfering; Small Molecule Libraries; Tranylcypromine; Vorinostat | 2017 |